Pentagon opens door to biobased suppliers—but only if they can prove it
H.R. 5191 — To direct the Under Secretary of Defense for Research and Engineering to issue guidance for private entities on demonstrating how biobased products meet Department of Defense requirements, and for other purposes. · Filed by Ro Khanna (D-CA) · 2 cosponsors · Introduced Sep 8, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Pentagon's research office to create guidance helping private companies prove their biobased products (made from living organisms or biological processes) meet military standards, and requires an independent audit to check whether current Pentagon procurement rules accidentally exclude such products. The goal is to open Pentagon purchasing to more biobased alternatives.
Why we flagged it
The bill's core function is to remove barriers to biobased product entry into Pentagon procurement by mandating guidance and auditing existing requirements for hidden bias. It is not a subsidy or carve-out, but a transparency and competitive-access measure.
What the text implies
- The audit may reveal that Pentagon requirements were written to favor incumbent suppliers or fossil-fuel-based products, creating political pressure to rewrite standards — potentially disrupting existing contracts.
- Biobased product guidance could accelerate adoption of biotech-derived materials in defense supply chains, shifting procurement patterns away from traditional petrochemical suppliers.
The full analysis lists 3 implications of this text.
Who stands to gain
biobased product manufacturers; biotech and agricultural biotechnology companies; companies developing sustainable alternatives to petrochemical-based defense materials